Biologics in rheumatoid arthritis--recommendations for Swiss practice

Dudler, Jean; Möller, Burkhard; Michel, Beat A; Villiger, Peter M (2011). Biologics in rheumatoid arthritis--recommendations for Swiss practice. Swiss medical weekly, 141, w13189. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13189

Full text not available from this repository. (Request a copy)

The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners in their daily use of those agents, to reflect the current "best practice" in Switzerland.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Möller, Burkhard, Villiger, Peter Matthias

ISSN:

1424-7860

Publisher:

EMH Schweizerischer Ärzteverlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:23

Last Modified:

05 Dec 2022 14:06

Publisher DOI:

10.4414/smw.2011.13189

PubMed ID:

21557111

Web of Science ID:

000290583200003

URI:

https://boris.unibe.ch/id/eprint/7956 (FactScience: 213344)

Actions (login required)

Edit item Edit item
Provide Feedback